How a pill approved 25 years ago transformed cancer treatment

The Food and Drug Administration approved Gleevec in 2001 to treat a form of leukemia, marking a new era in cancer care. This approval transformed cancer treatment over the past 25 years. Gleevec has had a significant impact on cancer treatment since its introduction.